Research Article
The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study
Table 1
Patients’ demographic and preoperative clinical characteristics.
| | Variables | CTR ≤ 0.83 | CTR > 0.83 | Total | value |
| | Age (mean, SD, n = 109) | 59.8 ± 11.7 | 63.8 ± 8.6 | 62.6 ± 9.7 | 0.052 |
| | Gender (n, %) | | Male | 21 (65.6%) | 50 (64.9%) | 71 (65.1%) | 0.945 | | Female | 11 (34.4%) | 27 (35.1%) | 38 (34.9%) |
| | Tumor location (n, %) | | | | 0.517 | | Hilus | 9 (29%) | 23 (29.5%) | 32 (29.4%) | | Gallbladder | 0 (0%) | 1 (1.3%) | 1 (0.9%) | | Common bile duct | 17 (54.8%) | 39 (50.0%) | 56 (51.4%) | | Ampulla | 5 (16.1%) | 9 (11.5%) | 14 (12.8%) | | Intrahepatic | 0 (3.1%) | 6 (7.7%) | 6 (5.5%) |
| | TNM staging (n, %) | | | | 0.073 | | 0 | 2 (6.5%) | 0 (0%) | 2 (1.8%) | | I | 11 (35.5%) | 18 (23.1%) | 29 (26.6%) | | II | 8 (25.8%) | 30 (38.5%) | 38 (34.9%) | | III | 10 (32.3%) | 27 (34.6%) | 37 (33.9%) | | IV | 0 (0%) | 3 (3.8%) | 3 (2.8%) |
| | Residual tumor stage (n, %) | | | | 0.438 | | R0 | 24 (77.4%) | 57 (73.1%) | 81 (74.3%) | | R1 | 7 (22.6%) | 17 (21.8%) | 24 (22%) | | R2 | 0 (0%) | 4 (5.1%) | 4 (3.7%) |
| | Pathological grading (n, %) | | | | 0.184 | | Low grade | 9 (29.0%) | 11 (14.1%) | 20 (18.3%) | | Middle grade | 14 (45.2%) | 45 (57.7%) | 59 (54.1%) | | High grade | 8 (25.8%) | 22 (28.2%) | 30 (27.5%) |
| | Jaundice (n, %) | | | | 0.149 | | Yes | 27 (87.1%) | 56 (71.8%) | 83 (76.1%) | | No | 4 (12.9%) | 22 (28.2%) | 26 (23.9%) |
|
|
CTR: CA19-9/TBIL ratio.
|
